BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30409518)

  • 1. Lipid bilayer position and orientation of novel carprofens, modulators of γ-secretase in Alzheimer's disease.
    Salnikov E; Drung B; Fabre G; Itkin A; Otyepka M; Dencher NA; Schmidt B; Hauß T; Trouillas P; Bechinger B
    Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2224-2233. PubMed ID: 30409518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics.
    Mouchlis VD; Melagraki G; Zacharia LC; Afantitis A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of the amyloid precursor protein by γ-secretase at the synaptic plasma membrane.
    Audagnotto M; Kengo Lorkowski A; Dal Peraro M
    Biochem Biophys Res Commun; 2018 Mar; 498(2):334-341. PubMed ID: 29097209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators.
    Narlawar R; Pérez Revuelta BI; Haass C; Steiner H; Schmidt B; Baumann K
    J Med Chem; 2006 Dec; 49(26):7588-91. PubMed ID: 17181139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gamma-secretase activity in Alzheimer's disease.
    Zhou S; Zhou H; Walian PJ; Jap BK
    Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing.
    Somavarapu AK; Kepp KP
    ACS Chem Neurosci; 2017 Nov; 8(11):2424-2436. PubMed ID: 28841371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Modulation of Intact γ-Secretase Structural Dynamics.
    Lee JY; Feng Z; Xie XQ; Bahar I
    Biophys J; 2017 Dec; 113(12):2634-2649. PubMed ID: 29262358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Alzheimer's Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides.
    Siegel G; Gerber H; Koch P; Bruestle O; Fraering PC; Rajendran L
    Cell Rep; 2017 Jun; 19(10):1967-1976. PubMed ID: 28591569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production.
    Dimitrov M; Alattia JR; Lemmin T; Lehal R; Fligier A; Houacine J; Hussain I; Radtke F; Dal Peraro M; Beher D; Fraering PC
    Nat Commun; 2013; 4():2246. PubMed ID: 23907250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipidome associated with the γ-secretase complex is required for its integrity and activity.
    Ayciriex S; Gerber H; Osuna GM; Chami M; Stahlberg H; Shevchenko A; Fraering PC
    Biochem J; 2016 Feb; 473(3):321-34. PubMed ID: 26811537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease.
    Voytyuk I; De Strooper B; Chávez-Gutiérrez L
    Biol Psychiatry; 2018 Feb; 83(4):320-327. PubMed ID: 28918941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production.
    Sano O; Tsujita M; Shimizu Y; Kato R; Kobayashi A; Kioka N; Remaley AT; Michikawa M; Ueda K; Matsuo M
    PLoS One; 2016; 11(5):e0155400. PubMed ID: 27196068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homodimerization Protects the Amyloid Precursor Protein C99 Fragment from Cleavage by γ-Secretase.
    Winkler E; Julius A; Steiner H; Langosch D
    Biochemistry; 2015 Oct; 54(40):6149-52. PubMed ID: 26403946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in gamma-secretase modulation.
    Pissarnitski D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production.
    Zhou S; Zhou H; Walian PJ; Jap BK
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7499-504. PubMed ID: 15890777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane trafficking and proteolytic activity of γ-secretase in Alzheimer's disease.
    Kanatsu K; Tomita T
    Biol Chem; 2016 Sep; 397(9):827-35. PubMed ID: 27390881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID-derived gamma-secretase modulators. Part III: Membrane anchoring.
    Baumann S; Höttecke N; Schubenel R; Baumann K; Schmidt B
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6986-90. PubMed ID: 19879754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.